In addition, KM-plot survival analysis revealed that a higher C3 level indicated shorter survival in lung cancer patients who received chemotherapy, while a higher C3 level indicated longer survival in lung cancer patients who did not receive chemotherapy (https://kmplot.com) (Fig. 1E), suggesting the dual role of complement in different contexts of cancer [39]. This evidence concerns the gene C3 and cancer.